Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma

• Published in: Genome research Vol. 30; no. 9; pp. 1217 - 1227
• Main Authors: Ordoñez, Raquel, Kulis, Marta, Russiñol, Nuria, Chapaprieta, Vicente, Carrasco-Leon, Arantxa, García-Torre, Beatriz, Charalampopoulou, Stella, Clot, Guillem, Beekman, Renée, Meydan, Cem, Duran-Ferrer, Martí, Verdaguer-Dot, Núria, Vilarrasa-Blasi, Roser, Soler-Vila, Paula, Garate, Leire, Miranda, Estíbaliz, San José-Enériz, Edurne, Rodriguez-Madoz, Juan R, Ezponda, Teresa, Martínez-Turrilas, Rebeca, Vilas-Zornoza, Amaia, Lara-Astiaso, David, Dupéré-Richer, Daphné, Martens, Joost H A, El-Omri, Halima, Taha, Ruba Y, Calasanz, Maria J, Paiva, Bruno, San Miguel, Jesus, Flicek, Paul, Gut, Ivo, Melnick, Ari, Mitsiades, Constantine S, Licht, Jonathan D, Campo, Elias, Stunnenberg, Hendrik G, Agirre, Xabier, Prosper, Felipe, Martin-Subero, Jose I
• Format: Journal Article
• Language: English
• Published: United States Cold Spring Harbor Laboratory Press 01.09.2020
• Subjects: Cell activation; Chromatin; Enhancers; Genotype & phenotype; Lymphocytes B; Multiple myeloma; NF-κB protein; Osteoblastogenesis; Oxidative stress; p53 Protein; Phenotypes; Plasma; Plasma cells; Regulatory sequences; Thioredoxin; TOR protein
• ISSN: 1088-9051; 1549-5469
• DOI: 10.1101/gr.265520.120

Multiple myeloma (MM) is a plasma cell neoplasm associated with a broad variety of genetic lesions. In spite of this genetic heterogeneity, MMs share a characteristic malignant phenotype whose underlying molecular basis remains poorly characterized. In the present study, we examined plasma cells from MM using a multi-epigenomics approach and demonstrated that, when compared to normal B cells, malignant plasma cells showed an extensive activation of regulatory elements, in part affecting coregulated adjacent genes. Among target genes up-regulated by this process, we found members of the NOTCH, NF-kB, MTOR signaling, and TP53 signaling pathways. Other activated genes included sets involved in osteoblast differentiation and response to oxidative stress, all of which have been shown to be associated with the MM phenotype and clinical behavior. We functionally characterized MM-specific active distant enhancers controlling the expression of thioredoxin ( ), a major regulator of cellular redox status and, in addition, identified as a novel essential gene for MM. Collectively, our data indicate that aberrant chromatin activation is a unifying feature underlying the malignant plasma cell phenotype.